225 related articles for article (PubMed ID: 16718267)
1. Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines.
Shellman YG; Makela M; Norris DA
Melanoma Res; 2006 Jun; 16(3):207-11. PubMed ID: 16718267
[TBL] [Abstract][Full Text] [Related]
2. [Involvement of matrix metalloproteinases (MMPs) in cutaneous melanoma progression].
Ntayi C; Hornebeck W; Bernard P
Pathol Biol (Paris); 2004 Apr; 52(3):154-9. PubMed ID: 15063935
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2001; 15(1):57-64. PubMed ID: 11286131
[TBL] [Abstract][Full Text] [Related]
4. Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography.
Kurschat P; Wickenhauser C; Groth W; Krieg T; Mauch C
J Pathol; 2002 Jun; 197(2):179-87. PubMed ID: 12015741
[TBL] [Abstract][Full Text] [Related]
5. Effects of cytokines on matrix metalloproteinase expression in oral squamous cell carcinoma in vitro.
Sundelin K; Roberg K; Grénman R; Håkansson L
Acta Otolaryngol; 2005 Jul; 125(7):765-73. PubMed ID: 16012040
[TBL] [Abstract][Full Text] [Related]
6. Influence of cultured dermal fibroblasts on human melanoma cell proliferation, matrix metalloproteinase-2 (MMP-2) expression and invasion in vitro.
Ntayi C; Hornebeck W; Bernard P
Arch Dermatol Res; 2003 Nov; 295(6):236-41. PubMed ID: 14530987
[TBL] [Abstract][Full Text] [Related]
7. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
Braundmeier AG; Nowak RA
Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
[TBL] [Abstract][Full Text] [Related]
8. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells.
MacDougall JR; Bani MR; Lin Y; Rak J; Kerbel RS
Cancer Res; 1995 Sep; 55(18):4174-81. PubMed ID: 7664294
[TBL] [Abstract][Full Text] [Related]
9. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
Bérubé M; Deschambeault A; Boucher M; Germain L; Petitclerc E; Guérin SL
Mol Vis; 2005 Dec; 11():1101-11. PubMed ID: 16379022
[TBL] [Abstract][Full Text] [Related]
10. Ultraviolet radiation induces release of MIA: a new mechanism for UVR-induced progression of melanoma.
Marr DG; Poser I; Shellman YG; Bosserhoff AK; Norris DA
Int J Oncol; 2004 Jul; 25(1):105-11. PubMed ID: 15201995
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the extracellular matrix remodeling by lutein in dermal fibroblasts, melanoma cells, and ultraviolet radiation exposed fibroblasts.
Philips N; Keller T; Hendrix C; Hamilton S; Arena R; Tuason M; Gonzalez S
Arch Dermatol Res; 2007 Oct; 299(8):373-9. PubMed ID: 17710425
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of matrix metalloproteinase-2 by fibroblasts in co-cultures with keratinocytes, basal cell carcinoma and melanoma.
Chen GS; Lu MP; Wu MT
J Dermatol; 2006 Sep; 33(9):609-15. PubMed ID: 16958805
[TBL] [Abstract][Full Text] [Related]
14. Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression.
Redondo P; Lloret P; Idoate M; Inoges S
Clin Exp Dermatol; 2005 Sep; 30(5):541-5. PubMed ID: 16045689
[TBL] [Abstract][Full Text] [Related]
15. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
[TBL] [Abstract][Full Text] [Related]
16. Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion.
Schnaeker EM; Ossig R; Ludwig T; Dreier R; Oberleithner H; Wilhelmi M; Schneider SW
Cancer Res; 2004 Dec; 64(24):8924-31. PubMed ID: 15604254
[TBL] [Abstract][Full Text] [Related]
17. Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma.
Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
Arch Dermatol Res; 2005 Oct; 297(4):154-60. PubMed ID: 16047212
[TBL] [Abstract][Full Text] [Related]
18. Biophytum sensitivum (L.) DC inhibits tumor cell invasion and metastasis through a mechanism involving regulation of MMPs, prolyl hydroxylase, lysyl oxidase, nm23, ERK-1, ERK-2, STAT-1, and proinflammatory cytokine gene expression in metastatic lung tissue.
Guruvayoorappan C; Kuttan G
Integr Cancer Ther; 2008 Mar; 7(1):42-50. PubMed ID: 18292594
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
Väisänen AH; Kallioinen M; Turpeenniemi-Hujanen T
Hum Pathol; 2008 Mar; 39(3):377-85. PubMed ID: 18187184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]